Is circulating nitrite a directly acting vasodilator?: Authors' reply [2]

Clinical Science

Volumn 103, Issue 1, 2002, Pages 108-110

  Demoncheaux, E A G ^a   Higenbottam, T W ^a   Foster, P J ^a   Borland, C D R ^a   Smith, A P L ^a   Marriott, H M ^a   Bee, D ^a   Akamine, S ^a   Davies, M B ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; METALLOPROTEIN; NITRIC OXIDE; NITRITE; NITROUS ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; KINETICS; LETTER; MOLECULAR INTERACTION; MOLECULAR WEIGHT; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PULMONARY ARTERY; STOICHIOMETRY; SWINE; VASODILATATION;

EID: 0036307278     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (21)

1. Circulating nitrite anions are a directly acting vasodilator and are donors for nitric oxide
2. Exhaled NO, ideas on its origin and physiological meaning
3. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor
4. Potential therapeutic uses of S-nitrosothiols
5. Nitric oxide gas decreases endothelin-1 mRNA in cultured pulmonary artery endothelial cells
6. The direct and indirect action of inhaled agents on the lung and its circulation: Lessons for clinical science
7. Solubility equilibria of the nitrogen oxides and oxyacids in dilute aqueous solution
8. Reaction mechanisms of inorganic nitrogen compounds
9. (S)NO signals: Translocation, regulation, and a consensus motif
10. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols
11. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide
12. Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: Implications for altered autocrine and paracrine functions of EDRF
13. Endothelium-derived relaxing factor from pulmonary artery and vein possess pharmacological and chemical properties identical to those of nitric oxide radical
14. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
15. Endothelium-derived relaxing factor is a nitrosyl iron complex with thiol ligands
16. Understanding the controversy over the identity of EDRF
17. Introduction to EDRF research
18. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione
19. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
20. The biology of nitrogen oxides in the airways
21. Whole body nitric oxide production is impaired in patients with primary pulmonary hypertension